SCHEDULE: PMV Pharma: PFM Health Sciences Reports 0% Stake

PFM Health Sciences and related entities filed an amended Schedule 13G, reporting zero beneficial ownership in PMV Pharmaceuticals, Inc.

Summary

• PFM Health Sciences, LP, PFM Health Sciences GP, LLC, Partner Asset Management, LLC, and Brian D. Grossman (collectively, the "Reporting Persons") filed an Amendment No. 2 to Schedule 13G.
• The filing pertains to common stock, par $0.00001 per share, of PMV Pharmaceuticals, Inc. (CUSIP: 69353Y103).
• As of the event date of June 30, 2025, the Reporting Persons collectively beneficially own 0 shares, representing 0.0% of the outstanding common stock.
• The Reporting Persons explicitly state that the securities were not acquired or held for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: The filing is neutral as it reports zero beneficial ownership, indicating no significant change in the reporting entities' stake in the company.

Stakeholder Impact

• Minimal direct impact on shareholders, employees, customers, suppliers, or creditors as the filing reports no beneficial ownership by the reporting entities.

Key Dates

Keywords

PMV Pharmaceuticals, PFM Health Sciences, Schedule 13G, beneficial ownership, institutional ownership, common stock